Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mats Wahlstrom Insider Profile
4 Followers
Mats Wahlstrom, Director at Coherus Biosciences, holds 2.67M shares in TriSalus Life Sciences (Ticker: TLSI), holds 99.99K shares in Coherus Biosciences (Ticker: CHRS).
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+20.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mats Wahlstrom holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mats Wahlstrom
Mats Wahlstrom's Trading History
Coherus Biosciences
Feb 15, 2024
Director
Uninformative Buy
―
$117.99K
TriSalus Life Sciences
Dec 19, 2024
Director, Ten Percent Owner
Uninformative Buy
100.00K
$13.62M
List of latest transactions for each holding click on a transaction to see Mats Wahlstrom's performance on stock
You May Also Like
Mats Wahlstrom insider profile FAQ
What is the percentage of profitable transactions made by Mats Wahlstrom?
The percentage of profitable transactions made by Mats Wahlstrom is 100%.
What is the average return per transaction made by Mats Wahlstrom?
The average return per transaction made by Mats Wahlstrom is 20.50%.
What stocks does Mats Wahlstrom hold?
Mats Wahlstrom holds: CHRS, TLSI stocks.
What was Mats Wahlstrom’s latest transaction?
Mats Wahlstrom latest transaction was an Uninformative Buy of $100.00K.
What was Mats Wahlstrom's most profitable transaction?
Mats Wahlstrom’s most profitable transaction was an Informative Buy of TLSI stock on November 25, 2024. The return on the trade was 27.20%.
What is Mats Wahlstrom's role in Coherus Biosciences?
Mats Wahlstrom's role in Coherus Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.